217 related articles for article (PubMed ID: 28120430)
1. Morcellating uterine mesenchymal tumors: The pathologist's view.
Pavlakis K; Messini I; Yiannou P; Gavresea T; Chrysanthakis D; Hilaris G; Panoskaltsis T
J Obstet Gynaecol Res; 2017 Mar; 43(3):580-586. PubMed ID: 28120430
[TBL] [Abstract][Full Text] [Related]
2. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
Mowers EL; Skinner B; McLean K; Reynolds RK
J Minim Invasive Gynecol; 2015; 22(4):601-6. PubMed ID: 25596464
[TBL] [Abstract][Full Text] [Related]
3. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms.
Seidman MA; Oduyebo T; Muto MG; Crum CP; Nucci MR; Quade BJ
PLoS One; 2012; 7(11):e50058. PubMed ID: 23189178
[TBL] [Abstract][Full Text] [Related]
5. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.
Raspagliesi F; Maltese G; Bogani G; Fucà G; Lepori S; De Iaco P; Perrone M; Scambia G; Cormio G; Bogliolo S; Bergamini A; Bifulco G; Casali PG; Lorusso D
Gynecol Oncol; 2017 Jan; 144(1):90-95. PubMed ID: 27817933
[TBL] [Abstract][Full Text] [Related]
6. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy.
Zhang J; Zhang J; Dai Y; Zhu L; Lang J; Leng J
Int J Gynaecol Obstet; 2015 Aug; 130(2):195-9. PubMed ID: 26117552
[TBL] [Abstract][Full Text] [Related]
8. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG
Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345
[TBL] [Abstract][Full Text] [Related]
9. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
Yilmaz A; Rush DS; Soslow RA
Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
[TBL] [Abstract][Full Text] [Related]
10. Low-Grade Endometrial Stromal Sarcoma Diagnosed 8 Years After Hysterectomy With Morcellation.
Sanneh A; Murdock T; Wethington SL; Fader AN; Xing D; Beavis AL
Obstet Gynecol; 2020 Aug; 136(2):365-368. PubMed ID: 32649495
[TBL] [Abstract][Full Text] [Related]
11. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
Skorstad M; Kent A; Lieng M
Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
[TBL] [Abstract][Full Text] [Related]
12. Incidental power morcellation of malignancy: a retrospective cohort study.
Graebe K; Garcia-Soto A; Aziz M; Valarezo V; Heller PB; Tchabo N; Tobias DH; Salamon C; Ramieri J; Dise C; Slomovitz BM
Gynecol Oncol; 2015 Feb; 136(2):274-7. PubMed ID: 25740603
[TBL] [Abstract][Full Text] [Related]
13. Incidental gynecologic neoplasms in morcellated uterine specimens: a case series with follow-up.
Ehdaivand S; Simon RA; Sung CJ; Steinhoff MM; Lawrence WD; Quddus MR
Hum Pathol; 2014 Nov; 45(11):2311-7. PubMed ID: 25257577
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease.
Von Bargen EC; Grimes CL; Mishra K; Wang R; Haviland MJ; Hacker MR; Carnevale JA; Estes AJ; Elkadry EA
Int J Gynaecol Obstet; 2017 May; 137(2):123-128. PubMed ID: 28170091
[TBL] [Abstract][Full Text] [Related]
15. Morcellation of occult uterine malignancies: an Australian single institution retrospective study.
Tan A; Salfinger S; Tan J; Cohen P
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):503-6. PubMed ID: 26314239
[TBL] [Abstract][Full Text] [Related]
16. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
17. [Three patients with differing manifestations of uterine sarcoma].
Lam JN; Nagel HT; Loyson SA; Peters AA
Ned Tijdschr Geneeskd; 2006 Feb; 150(6):329-35. PubMed ID: 16503026
[TBL] [Abstract][Full Text] [Related]
18. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
19. Uterine endometrial stromal sarcoma located in uterine myometrium: MRI appearance.
Ueda M; Otsuka M; Hatakenaka M; Torii Y
Eur Radiol; 2000; 10(5):780-2. PubMed ID: 10823633
[TBL] [Abstract][Full Text] [Related]
20. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors.
Oliva E; Clement PB; Young RH
Int J Gynecol Pathol; 2002 Jan; 21(1):48-55. PubMed ID: 11781523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
